Woodrow D Anderson, Chief Accounting Officer at Indivior Pharmaceuticals, bought INDV on Aug 5, 2026

Data as of Oct 16

▲ BUY$54.4K1,500 shares at $36.28Woodrow D Anderson Chief Accounting OfficerINDV Indivior Pharmaceuticals, Inc.

Watch INDV

Traded: Aug 5, 2026
Disclosed: Aug 5, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

INDVSimilar stocks (XLV — its sector index fund), rebased to INDV's price on the disclosure day

INDV since disclosure

−16.2%

Similar stocks (XLV) since disclosure

+7.6%

XLV — its sector index fund

Change in closing price from Aug 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on INDV →